Beneficência Portuguesa De São Paulo
Clinical trials sponsored by Beneficência Portuguesa De São Paulo, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Antibiotic showdown: can a newer drug match the standard for dangerous infections? Results expected Aug 2027 (estimated)
-
Antibiotic showdown: can a newer drug match the standard for dangerous infections?
Disease control Recruiting nowResearchers are testing whether ceftolozane/tazobactam works as well as meropenem for treating febrile neutropenia in patients who carry or are at risk of ESBL-producing bacteria. Participants receive one of the two antibiotics intravenously every 8 hours. The trial measures how …
Phase 4 • Sponsor: Beneficência Portuguesa de São Paulo • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Genetic panel aims to spot heart risk before cancer therapy begins
Diagnosis Recruiting nowThis study tests whether a genetic and epigenetic panel can predict heart damage caused by chemotherapy or immunotherapy in breast cancer patients. Researchers will analyze blood samples from 1,000 participants before and during treatment to see if certain genetic markers signal …
Sponsor: Beneficência Portuguesa de São Paulo • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Brazilian diabetes prevention program aims to stop type 2 diabetes before it starts
Prevention Recruiting nowThis study tests a 3-year lifestyle program for 1,305 Brazilian adults at high risk for type 2 diabetes. The program combines in-person and online counseling on diet, exercise, sleep, and stress. Researchers will track who develops diabetes and measure weight, blood sugar, and qu…
Sponsor: Beneficência Portuguesa de São Paulo • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC